Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OraSure TechnologiesOSUR -1.85%57 EV-to-OCF is -2.52 as of Aug. 26, 2026. GuruFocus rates OSUR with a GF Score™ of 57/100 and a GF Value™ of $2.11 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, OraSure Technologies ranks better than 68.66% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, OraSure Technologies's Enterprise Value is $108.1 Mil.
OraSure Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-42.9 Mil. Therefore, OraSure Technologies's EV-to-OCF for today is -2.52.
The historical rank and industry rank for OraSure Technologies's EV-to-OCF or its related term are showing as below:
OSUR'
s EV-to-OCF Range Over the Past 10 Years
Min: -598.56 Med: 4.3 Max: 764.39
Current: -2.52
During the past 13 years, the highest EV-to-OCF of OraSure Technologies was 764.39. The lowest was -598.56. And the median was 4.30.
OSUR's EV-to-OCF is ranked better than 68.66% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.695
vs OSUR: -2.52
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
OraSure Technologies's PE Ratio (TTM) for today is calculated as:
OraSure Technologies's share price for today is $3.72.
OraSure Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.690.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
OraSure Technologies EV-to-OCF Related Terms
OraSure Technologies EV-to-OCF Historical Data
* Premium members only.
The historical data trend for OraSure Technologies's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, OraSure Technologies's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's EV-to-OCF falls into.
OraSure Technologies's current Enterprise Value is $108.1 Mil.
OraSure Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies (OSUR) has a EV-to-OCF of -2.52 as of Aug. 26, 2026. According to the industry distribution chart, OraSure Technologies ranks #267 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 31.3%.
Is OraSure Technologies' EV-to-OCF too high?
OraSure Technologies' current EV-to-OCF is -2.52. Based on the distribution chart, OraSure Technologies ranks #267 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, OraSure Technologies has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OraSure Technologies' EV-to-OCF compare to SMTI and UTMD?
According to the Medical Devices & Instruments industry distribution chart, OraSure Technologies ranks #267 out of 852 companies for EV-to-OCF. This puts OraSure Technologies in the upper half of its industry. The industry median EV-to-OCF is 7.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.70, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OraSure Technologies's current EV-to-OCF is -2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OraSure Technologies stock overvalued right now?
Based on GuruFocus' analysis, OraSure Technologies (OSUR) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.11, compared to a current price of $3.72 — trading 76.3% above its estimated fair value. The current EV-to-OCF is -2.52. OraSure Technologies' overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For OraSure Technologies (OSUR), the current EV-to-OCF is -2.52 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OraSure Technologies (OSUR) Overvalued in 2026?
Based on GuruFocus' analysis, OraSure Technologies stock appears to be overvalued.
The current stock price of $3.72 is trading 76.3% above its estimated GF Value™ of $2.11.
GuruFocus considers OraSure Technologies to be Significantly Overvalued.
Key valuation signals for OSUR:
EV-to-OCF: -2.52
GF Value™: $2.11 vs. price of $3.72 (76.3% above fair value)
No single metric tells the full story. See the OSUR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
57GF Score
Get the complete analysis for OSUR
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSUR has been successfully added to your 
